In relation to well being and wellness, folks wish to imagine that the subsequent miracle product could be the one which fixes what ails them.
CBD, which is authorized in most states so long as it is derived from hemp, has been a product many People have turned to regardless of their being little analysis as to its effectiveness.
“CBD products are in high demand worldwide, with many people seeking alternative treatments for medical conditions or general health and well-being benefits,” based on a analysis paper from Science Direct.
Demand, nevertheless, shouldn’t be scientific proof {that a} product works.
“The use of CBD products often relies on self-medication and lacks sufficient scientific evidence. Improved communication between patients and healthcare professionals is needed to ensure informed decisions and address potential interactions with other medications. Scientific evidence on CBD is currently limited,” the information exhibits.
Pure Science Lab has been a pacesetter within the CBD area, however market circumstances and debt have compelled the corporate to file for Chapter 11 chapter, based on paperwork filed on Pacer Monitor.
CBD’s effectiveness stays an open query
Hemp, in contrast to THC or marijuana, has been legalized.
“In 2018, the U.S. Congress passed and signed into law the Agriculture Improvement Act. This law removed hemp from the federal Controlled Substances Act, effectively legalizing CBD if it comes from hemp. However, a few states have not removed hemp from their state’s-controlled substances acts, so legality of CBD products differs across states,” based on the Facilities for Illness Management (CDC).
And whereas there’s not quite a lot of knowledge exhibiting CBD gross sales knowledge, the market does look like rising.
“Annual retail sales of herbal dietary supplements in the United States totaled an estimated $15.551 billion in 2023, according to the nonprofit American Botanical Council’s (ABC’s) 2023 Herb Market Report. US consumers spent an additional $533 million on these products in 2023 compared to 2022 — a 4.4% increase in annual sales,” based on a press launch from the American Botanical Council.
SPINS’ 2024 Pure Merchandise Trade Tendencies report describes CBD as having moved right into a maturation section after peak progress, with slower enlargement in mainstream retail channels.”
“Today, while the market has yet to return to pre-Covid rates, the category is alive and well. CBD has earned its spot in the medicine cabinet with the ability to support multiple need states that American’s are looking for: sleep, anxiety, and pain support,” SPINS shared.
CBD has been utilized by a comparatively great amount of People.
“An estimated 10.5% of the US population reports using cannabidiol (CBD), a chemical compound extracted from cannabis that does not have psychoactive effects, for therapeutic purposes,” based on a JAMA Community assessment titled “Therapeutic Use of Cannabis and Cannabinoids.
The study questions the medical value of CBD.
“Evidence is insufficient for the use of cannabis or cannabinoids for most medical indications. Clear guidance from clinicians is essential to support safe, evidence-based decision-making. Clinicians should weigh benefits against risks when engaging patients in informed discussions about cannabis or cannabinoid use,” it added.
Pure Science Lab files Chapter 11 bankruptcy
Founded in 2014, Pure Science Lab has been a leader in the CBD space.
“Pure Science Lab provides premium, independent third party lab-tested cannabinoid formulations. From tinctures to teas, chocolates to creams, and softgels to sweets for you and your pet,” the company shared on its website.
The company claims its products help with pain management, sleep, and mental health.
The Food and Drug Administration (FDA), however, has made it clear that work needs to be done to verify any claims of the benefits of CBD.
More Bankruptcy:
- Key auto parts and services company files Chapter 11 bankruptcy
- Key travel brand files for Chapter 11 bankruptcy
- Self-driving-car company files for Chapter 11 bankruptcy protection
“There’s not enough evidence about CBD to confirm that it’s safe for use in foods or as a dietary supplement, FDA Deputy Commissioner Dr. Janet Woodcock said in a statement reported by the Associated Press.
“For example, we have not found adequate evidence to determine how much CBD can be consumed, and for how long, before causing harm,” she stated.
CBD is bought in retail shops in most U.S. states.
Shutterstock
Pure Science Lab Chapter 11 chapter details:
- Filed: April 3, 2026
- Courtroom: U.S. Chapter Courtroom for the Southern District of Florida
- Case quantity: 0:26-bk-14210
- Enterprise: CBD producer and retailer primarily based in Pompano Seashore, Florida
- Property: $50,001 to $100,000
- Liabilities: $1 million to $10 million
- Complete debt: Greater than $1 million reported
- Submitting kind: Chapter 11 (reorganization)
- Key difficulty: Firm cited {industry} headwinds, together with regulatory stress on hemp/CBD merchandise
- Trade context: The CBD sector is dealing with tightening rules and inconsistent federal oversight. The market has turn out to be more and more aggressive and fragmented (industry-wide pattern).
Supply: PacerMonitor
“Pure Science Lab is authorized to continue operating its business during the bankruptcy proceedings,” based on a doc signed by chapter choose Peter D. Russin, South Florida Enterprise Journal reported.
It is unclear what led to the chapter submitting.
Chad Van Horn, an legal professional representing Pure Science, didn’t instantly present a remark, to South Florida Enterprise Journal.
Associated: 110-year-old Residence Depot rival closes
